distigmine has been researched along with Myasthenic Syndromes, Congenital in 1 studies
distigmine : A carbamate ester resulting from the formal condensation of both carboxy groups of hexane-1,6-diylbis(methylcarbamic acid) with the hydroxy group of 3-hydroxy-1-methylpyridinium.
Myasthenic Syndromes, Congenital: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishigaki, K | 1 |
| Murakami, T | 1 |
| Ito, Y | 1 |
| Yanagisawa, A | 1 |
| Kodaira, K | 1 |
| Shishikura, K | 1 |
| Suzuki, H | 1 |
| Hirayama, Y | 1 |
| Osawa, M | 1 |
1 other study available for distigmine and Myasthenic Syndromes, Congenital
| Article | Year |
|---|---|
[Treatment approach to congenital myasthenic syndrome in a patient with acetylcholine receptor deficiency].
Topics: 4-Aminopyridine; Adolescent; Amifampridine; Diagnosis, Differential; Humans; Male; Myasthenic Syndro | 2009 |